Payments to Third Parties. Subject to Section 2.6 (Third Party In-Licenses), each Party will be solely responsible for any payments due to Third Parties under any agreement entered into by such Party prior to or after the Effective Date.
Appears in 1 contract
Sources: Collaboration and License Agreement (Kiniksa Pharmaceuticals, Ltd.)
Payments to Third Parties. Subject to Section 2.6 2.7 (Third Party In-Licenses), each Party will be solely responsible for any payments due to Third Parties under any agreement entered into by such Party prior to or after the Effective Date.
Appears in 1 contract
Sources: Collaboration and License Agreement (Kiniksa Pharmaceuticals, Ltd.)
Payments to Third Parties. Subject to Section 2.6 2.5 (Third Party In-Licenses) and Section 10.3.3(c) (Third Party Patent Rights), each Party will be solely [***] responsible for any [***] payments due to Third Parties under any agreement entered into by such Party prior to or after the Effective Date.
Appears in 1 contract
Sources: Collaboration and License Agreement (ImmunoGen, Inc.)
Payments to Third Parties. Subject to Section 2.6 12.4 (Third Party In-Licenses) and Section 8.3.3(b) (Third Party Patent Rights and Know-How), each Party will be solely responsible for any payments due to Third Parties under any agreement entered into by such Party prior to or after the Effective Date.
Appears in 1 contract
Sources: Commercialization and License Agreement (Biocryst Pharmaceuticals Inc)
Payments to Third Parties. Subject to Section 2.6 2.5 (Third Party In-Licenses) and Section 8.3.3(b) (Third Party Patent Rights), each Party will be solely responsible for any payments due to Third Parties under any agreement entered into by such Party prior to or after the Effective Date.
Appears in 1 contract
Sources: Collaboration and License Agreement (Viridian Therapeutics, Inc.\DE)
Payments to Third Parties. Subject to Section 2.6 12.3 (Third Party In-Licenses), each Party will be solely responsible for any payments due to Third Parties under any agreement entered into by such each Party prior to or after the Effective Date.
Appears in 1 contract
Sources: License, Supply, and Distribution Agreement (KalVista Pharmaceuticals, Inc.)